Financial giants have made a conspicuous bearish move on SpringWorks Therapeutics. Our analysis of options history for ...
根据监管文件显示,SpringWorks Therapeutics, Inc.(NASDAQ:SWTX)首席运营官Edris Badreddin于2025年3月3日出售了大量公司普通股。Badreddin以每股53.12美元至56.20美元的价格出售了20,000股,交易总额约为1,084,592美元。在SWTX过去六个月股价上涨26%且保持93%高毛利率的强劲势头下完成了此次交易。根据 ...
Shares of SpringWorks Therapeutics SWTX have rallied 32.9% in the past three months compared with the industry’s increase of ...
The clinical-stage biopharmaceutical company saw the highest jump in retail interest after reporting positive topline data ...
根据提交给美国证券交易委员会的文件显示,SpringWorks Therapeutics, Inc. (NASDAQ: SWTX )的首席执行官Islam Saqib最近进行了一系列股票交易。3月3日,Saqib通过多笔交易共计出售了48,000股公司普通股。这些股票的售价在每股52.97美元至56.89美元之间,总价值约266万美元。根据 InvestingPro ...
SpringWorks Therapeutics is working on new potential indications for its IP portfolio while running additional trials. See ...
【德国默克就收购美国生物技术公司 SpringWorks 进行深入谈判】德国医疗保健和技术集团默克公司周一表示,该公司正在 就收购美国癌症和罕见病制药商SpringWorks Therapeutics进行深入谈判。默克公司在声明中说,收购SpringWorks的谈判正在进行中。这家总部位于德国达姆施塔特(Darmstadt)的公司表示,尚未签署任何具有法律约束力的协议,也不确定交易是否会实现。
Barclays analyst Peter Lawson says SpringWorks Therapeutics (SWTX) this morning cancelled from the firm’s conference next week, following ...
Shares of SpringWorks Therapeutics SWTX have rallied 32.9% in the past three months compared with the industry’s increase of 2.7%. Here, we discuss the reasons for the same. Strong Launch of ...
Ogsiveo's net product revenues were $172 million in 2024. Last month, the FDA approved SpringWorks’ MEK inhibitor, Gomekli (mirdametinib) for the treatment of adult and pediatric patients 2 ...
While the company is in discussions to acquire SpringWorks, it did not elaborate on these talks in its earnings call.
On February 10, 2025, the Group confirmed advanced discussions about a potential acquisition of SpringWorks Therapeutics ( SWTX ), Inc., USA. At the time of the preparation of the Consolidated ...